WHO Africa Advances African Science by Promoting Peer-Reviewed Rese
This article is brought to you by IPS Noram in collaboration with INPS Japan and Soka Gakkai International in consultative status with ECOSOC. IPS UN Bureau Report   Follow @IPSNewsUNBureau !function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');   When the Man Who Built the Bombs Met the Man Who Dropped the Bombs… Ahead of UN Summit of the Future, Mobilizing Youth for Change UN Environmenta...
Source: IPS Inter Press Service - Health - April 29, 2024 Category: International Medicine & Public Health Authors: Maina Waruru Tags: Africa Development & Aid Editors' Choice Featured Headlines Health Humanitarian Emergencies Population Poverty & SDGs Sustainable Development Goals TerraViva United Nations IPS UN Bureau IPS UN Bureau Report SDGs for All World Source Type: news

WHO Africa Advances African Science by Promoting Peer-Reviewed Research
This article is brought to you by IPS Noram in collaboration with INPS Japan and Soka Gakkai International in consultative status with ECOSOC. IPS UN Bureau Report   Follow @IPSNewsUNBureau !function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');   When the Man Who Built the Bombs Met the Man Who Dropped the Bombs… Ahead of UN Summit of the Future, Mobilizing Youth for Change UN Environmenta...
Source: IPS Inter Press Service - Health - April 29, 2024 Category: International Medicine & Public Health Authors: Maina Waruru Tags: Africa Development & Aid Editors' Choice Featured Headlines Health Humanitarian Emergencies Population Poverty & SDGs Sustainable Development Goals TerraViva United Nations IPS UN Bureau IPS UN Bureau Report SDGs for All World Source Type: news

Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The company has told countries that it can supply only 18.8 million of the 29.6 million doses it was contracted to deliver this year. (Source: NYT Health)
Source: NYT Health - April 18, 2024 Category: Consumer Health News Authors: Stephanie Nolen Tags: Sexually Transmitted Diseases Vaccination and Immunization Developing Countries Cervical Cancer Human Papillomavirus (HPV) Women and Girls Medicine and Health Teenagers and Adolescence Children and Childhood Gardasil (Vaccine) Source Type: news

AACR: At-Home HPV Testing Boosts Cervical Cancer Screening Participation
FRIDAY, April 12, 2024 -- Mailed at-home self-sampling for human papillomavirus (HPV) testing increases cervical cancer screening participation in underscreened populations by almost threefold, according to a study presented at the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2024 Category: Pharmaceuticals Source Type: news

Disparities Seen in HPV Vaccine Uptake Among U.S. Adults
FRIDAY, March 29, 2024 -- There are sociodemographic disparities in human papillomavirus (HPV) vaccine uptake among 27- to 45-year-olds, according to a study published online March 28 in Human Vaccines& Immunotherapeutics.Natalie L.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 29, 2024 Category: Pharmaceuticals Source Type: news

Merck to Test Single-dose Regimen Of HPV Vaccine Gardasil 9 Merck to Test Single-dose Regimen Of HPV Vaccine Gardasil 9
Merck& Co said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the efficacy and safety of a...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 13, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Advantaged Households Have Lower Intent to Vaccinate Teens Against HPV
FRIDAY, March 1, 2024 -- A significant proportion of adolescents who are unvaccinated or not fully vaccinated against human papillomavirus (HPV) are from advantaged socioeconomic households, according to a study published online Feb. 19 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 1, 2024 Category: Pharmaceuticals Source Type: news

Which Families Are Less Likely to Get Teens the HPV Vaccine?
TUESDAY, Feb. 27, 2024 -- Well-to-do American families are more likely than poorer families to increase their children ’s risk of cervical cancer by skipping the human papillomavirus (HPV) vaccine, a new study has found.Nearly two-thirds of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 27, 2024 Category: General Medicine Source Type: news

No Increase Seen in HPV Vaccination Coverage From 2019 to 2022
THURSDAY, Feb. 22, 2024 -- Human papillomavirus (HPV) vaccination rates did not increase from 2019 to 2022, according to a study published online Feb. 20 in JAMA Network Open.Kalyani Sonawane, Ph.D., from the Medical University of South Carolina in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 22, 2024 Category: Pharmaceuticals Source Type: news

38.6 Percent of 9- to 17-Year-Olds Have Received at Least One HPV Vaccine Dose
WEDNESDAY, Feb. 14, 2024 -- In 2022, 38.6 percent of children aged 9 to 17 years had received one or more doses of human papillomavirus (HPV) vaccine, according to a February data brief published by the National Center for Health Statistics. Maria... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 14, 2024 Category: Pharmaceuticals Source Type: news

Women With High-Risk HPV Have Increased Risk for Heart Disease
FRIDAY, Feb. 9, 2024 -- Women with high-risk human papillomavirus (HR-HPV) infection have an increased risk for cardiovascular disease (CVD), according to a study published online Feb. 7 in the European Heart Journal. Hae Suk Cheong, M.D., Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 9, 2024 Category: Pharmaceuticals Source Type: news

Genital HPV infections – what community nurses need to know
Nurse specialist in genitourinary medicine Jodie Crossman provides an update on genital HPV infections, including latest statistics and how to advise patients on current prevention and treatment measures Genital Human Papilloma Virus (HPV) is often a big cause of concern for patients, with media stories and information campaigns largely focused on the life-altering effects of... Read moreThe post Genital HPV infections – what community nurses need to know appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - February 8, 2024 Category: Nursing Authors: Caroline Price Tags: Sexual health Vaccinations and infections Women's health HPV Source Type: news

High-Risk Strains of HPV Could Raise Women's Odds for Heart Death
WEDNESDAY, Feb. 7, 2024 -- Women are four times more likely to die from heart disease and six times more likely to die from stroke if infected with a high-risk strain of human papillomavirus (HPV), a new study warns.HPV already is known to cause... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 7, 2024 Category: General Medicine Source Type: news

High-Risk HPV in Women Heightens Risk of Heart Disease Death
(MedPage Today) -- Women with high-risk strains of human papillomavirus (HPV) had a far higher risk of death from certain types of cardiovascular disease (CVD), a prospective cohort study from Korea found. Compared to women without high-risk strains... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 7, 2024 Category: Cardiology Source Type: news

Budget 2024: Prescription for cervical cancer vaccine, new medical colleges
The government is planning to include the human papillomavirus (HPV) vaccine in the country's immunisation program, potentially making vaccines to prevent cervical cancer more affordable. Finance Minister Nirmala Sitharaman stated that the government aims to encourage vaccination for girls aged 9 to 14 to prevent cervical cancer. Currently, the HPV vaccine is available in private hospitals at a cost of up to ₹4,000 per dose. Additionally, the government plans to establish more medical colleges and upgrade Anganwadi centers for improved healthcare services and nutrition delivery. (Source: The Economic Times)
Source: The Economic Times - February 1, 2024 Category: Consumer Health News Source Type: news